Akums Drugs and Pharmaceuticals’s IPO will hit the market on July 30, 2024, and close on August 01, 2024. The Akums Drugs and Pharmaceuticals IPO GMP Kostak rate is subject to Sauda updated as of today. The Akums Drugs and Pharmaceuticals IPO Grey Market Premium has started with high premium rates at this time, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check Akums Drugs and Pharmaceuticals IPO subscription status here.
Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. The company primarily provides end-to-end solutions for product development and manufacturing research and development (R&D) of formulations, preparation and submission of regulatory dossiers in the Indian and global markets, and other testing services. The company is also engaged in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs).
Akums Drugs and Pharmaceuticals IPO Issue size of ₹1856.74 Crores, in which Fresh Issue of ₹680.00 Crores and Offer For Sale of ₹1176.74 Crores and issue price band has been fixed at ₹646 to ₹679 Per Share. The Akums Drugs and Pharmaceuticals IPO will be listed on August 06, 2024, NSE and BSE.
What is Akums Drugs and Pharmaceuticals IPO GMP Today?
■ The Akums Drugs and Pharmaceuticals IPO GMP Today Or Grey Market Premium is ₹45.
What are Akums Drugs and Pharmaceuticals IPO Kostak Rates Today?
■ The Akums Drugs and Pharmaceuticals IPO Kostak rate is ₹0.
What is Akums Drugs and Pharmaceuticals IPO Subject to Sauda Price Today?
■ The Akums Drugs and Pharmaceuticals IPO Subject to Sauda rates is ₹1100.
Akums Drugs and Pharmaceuticals IPO Approximately Returns?
■ The Akums Drugs and Pharmaceuticals IPO’s approximate return is 10%, which can also change according to the Market Sentiment.
Akums Drugs and Pharmaceuticals IPO GMP Live, Kostak, & Subject :
| Date | GMP | Kostak | Subject |
| 06 Aug 2024 | List:₹725.00 Gain:6.77% | ₹0 | ₹1100 |
| 05 Aug 2024 | ₹45  | ₹0 | ₹1100 |
| 04 Aug 2024 | ₹85 | ₹0 | ₹1400 |
| 03 Aug 2024 | ₹90 | ₹0 | ₹1600 |
| 02 Aug 2024 | ₹125 | ₹0 | ₹2100 |
| 01 Aug 2024 | ₹140 | ₹0 | ₹2400 |
| 31 Jul 2024 | ₹170 | ₹0 | ₹2800 |
| 30 Jul 2024 | ₹175 | ₹0 | ₹3000 |
| 29 Jul 2024 | ₹210  | ₹0 | ₹3500 |
| 28 Jul 2024 | ₹180 | ₹0 | ₹3000 |
| 27 Jul 2024 | ₹170 | ₹0 | ₹2800 |
| 26 Jul 2024 | ₹165 | ₹0 | ₹2800 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on some factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even decline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
| Akums Drugs and Pharmaceuticals IPO Details: Click Here Akums Drugs and Pharmaceuticals IPO Subscription: Click Here Akums Drugs and Pharmaceuticals IPO Allotment: Click Here Akums Drugs and Pharmaceuticals IPO Listing: Click Here |
All Akums Drugs and Pharmaceuticals IPO-related links are available here. If you want to know the details then click here.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.